The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Nonsteroidal anti-inflammatory drugs for dysmenorrhoea
Open accessAbstract
BACKGROUND: Dysmenorrhoea is a common gynaecological problem consisting of painful cramps accompanying menstruation, which in the absence of any underlying abnormality is known as primary dysmenorrhoea. Research has shown that women with dysmenorrhoea have high levels of prostaglandins, hormones known to cause cramping abdominal pain. Nonsteroidal anti-inflammatory drugs (NSAIDs) are drugs that act by blocking prostaglandin production. They inhibit the action of cyclooxygenase (COX), an enzyme responsible for the formation of prostaglandins. The COX enzyme exists in two forms, COX-1 and COX-2. Traditional NSAIDs are considered 'non-selective' because they inhibit both COX-1 and COX-2 enzymes. More selective NSAIDs that solely target COX-2 enzymes (COX-2-specific inhibitors) were launched in 1999 with the aim of reducing side effects commonly reported in association with NSAIDs, such as indigestion, headaches and drowsiness. OBJECTIVES: To determine the effectiveness and safety of NSAIDs in the treatment of primary dysmenorrhoea. SEARCH METHODS: We searched the following databases in January 2015: Cochrane Menstrual Disorders and Subfertility Group Specialised Register, Cochrane Central Register of Controlled Trials (CENTRAL, November 2014 issue), MEDLINE, EMBASE and Web of Science. We also searched clinical trials registers (ClinicalTrials.gov and ICTRP). We checked the abstracts of major scientific meetings and the reference lists of relevant articles. SELECTION CRITERIA: All randomised controlled trial (RCT) comparisons of NSAIDs versus placebo, other NSAIDs or paracetamol, when used to treat primary dysmenorrhoea. DATA COLLECTION AND ANALYSIS: Two review authors independently selected the studies, assessed their risk of bias and extracted data, calculating odds ratios (ORs) for dichotomous outcomes and mean differences for continuous outcomes, with 95% confidence intervals (CIs). We used inverse variance methods to combine data. We assessed the overall quality of the evidence using GRADE methods. MAIN RESULTS: We included 80 randomised controlled trials (5820 women). They compared 20 different NSAIDs (18 non-selective and two COX-2-specific) versus placebo, paracetamol or each other. NSAIDs versus placeboAmong women with primary dysmenorrhoea, NSAIDs were more effective for pain relief than placebo (OR 4.37, 95% CI 3.76 to 5.09; 35 RCTs, I(2) = 53%, low quality evidence). This suggests that if 18% of women taking placebo achieve moderate or excellent pain relief, between 45% and 53% taking NSAIDs will do so.However, NSAIDs were associated with more adverse effects (overall adverse effects: OR 1.29, 95% CI 1.11 to 1.51, 25 RCTs, I(2) = 0%, low quality evidence; gastrointestinal adverse effects: OR 1.58, 95% CI 1.12 to 2.23, 14 RCTs, I(2) = 30%; neurological adverse effects: OR 2.74, 95% CI 1.66 to 4.53, seven RCTs, I(2) = 0%, low quality evidence). The evidence suggests that if 10% of women taking placebo experience side effects, between 11% and 14% of women taking NSAIDs will do so. NSAIDs versus other NSAIDsWhen NSAIDs were compared with each other there was little evidence of the superiority of any individual NSAID for either pain relief or safety. However, the available evidence had little power to detect such differences, as most individual comparisons were based on very few small trials. Non-selective NSAIDs versus COX-2-specific selectorsOnly two of the included studies utilised COX-2-specific inhibitors (etoricoxib and celecoxib). There was no evidence that COX-2-specific inhibitors were more effective or tolerable for the treatment of dysmenorrhoea than traditional NSAIDs; however data were very scanty. NSAIDs versus paracetamolNSAIDs appeared to be more effective for pain relief than paracetamol (OR 1.89, 95% CI 1.05 to 3.43, three RCTs, I(2) = 0%, low quality evidence). There was no evidence of a difference with regard to adverse effects, though data were very scanty.Most of the studies were commercially funded (59%); a further 31% failed to state their source of funding. AUTHORS' CONCLUSIONS: NSAIDs appear to be a very effective treatment for dysmenorrhoea, though women using them need to be aware of the substantial risk of adverse effects. There is insufficient evidence to determine which (if any) individual NSAID is the safest and most effective for the treatment of dysmenorrhoea. We rated the quality of the evidence as low for most comparisons, mainly due to poor reporting of study methods.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Brown, J., & Brown, S. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004142.pub2 · Cited by 82
RetractedMeasuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Meta-analyses involving cross-over trials: methodological issues
Elbourne, D. R., Altman, D. G., Higgins, J. P., Curtin, F., Worthington, H. V., & Vail, A. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.140 · Cited by 2,305
Hawkey, C. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12154-2 · Cited by 1,173
Published by John Wiley & Sons Ltd
Modarresi, O. A. F., & Shakibaie, M. M. M. R. (2015) · Cited by 1,111
Nonsteroidal Antiinflammatory Drugs — Differences and Similarities
Oates, J. A., Wood, A. J. J., Brooks, P. M., & Day, R. O. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106133242407 · Cited by 775
Latthe, P., Latthe, M., Say, L., Gülmezoglu, M., & Khan, K. S. (2006) · BMC Public Health · doi:10.1186/1471-2458-6-177 · Cited by 764
Primary Dysmenorrhea: Advances in Pathogenesis and Management
Dawood, M. Y. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000230214.26638.0c · Cited by 690
Non-Steroidal Anti-Inflammatory Drugs: Current Status and Rational Therapeutic Use
Hart, F. D., & Huskisson, E. C. (1984) · Drugs · doi:10.2165/00003495-198427030-00004 · Cited by 507
Carrasco, J. M., Lope, V., Pérez-Gómez, B., Aragonés, N., Suárez, B., López-Abente, G., Rodríguez-Artalejo, F., & Pollán, M. (2006) · BMC Public Health · doi:10.1186/1471-2458-6-1 · Cited by 435
Prevalence and Impact of Dysmenorrhea on Hispanic Female Adolescents
Banikarim, C., Chacko, M. R., & Kelder, S. H. (2000) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.154.12.1226 · Cited by 404
Hillen, T. I. J., Grbavac, S. L., Johnston, P. J., Straton, J. A. Y., & Keogh, J. M. F. (1999) · Journal of Adolescent Health · doi:10.1016/s1054-139x(98)00147-5 · Cited by 289
Bonnar, J., & Sheppard, B. L. (1996) · BMJ · doi:10.1136/bmj.313.7057.579 · Cited by 275
Epidemiology of Nonsteroidal Anti-inflammatory Drug–Associated Gastrointestinal Injury
Griffin, M. R. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00207-6 · Cited by 274
Transcutaneous electrical nerve stimulation for primary dysmenorrhoea
Proctor, M., Farquhar, C., Stones, W., He, L., Zhu, X., & Brown, J. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002123 · Cited by 247
Self-citationCONVERSION OF ATRIAL FIBRILLATION TO SINUS RHYTHM BY DIRECT-CURRENT SHOCK
Oram, S., Davies, J. P. H., Weinbren, I., Taggart, P., & Kitchen, L. D. (1963) · The Lancet · doi:10.1016/s0140-6736(63)92799-5 · Cited by 234
Zahradnik, H.-P., Hanjalic-Beck, A., & Groth, K. (2010) · Contraception · doi:10.1016/j.contraception.2009.09.014 · Cited by 227
Herbal and dietary therapies for primary and secondary dysmenorrhoea
Proctor, M., & Murphy, P. A. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002124 · Cited by 193
Self-citationOral contraceptive pill for primary dysmenorrhoea
Wong, C. L., Farquhar, C., Roberts, H., & Proctor, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002120.pub3 · Cited by 189
Self-citationSurgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhoea
Proctor, M., Latthe, P., Farquhar, C., Khan, K., & Johnson, N. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001896.pub2 · Cited by 180
Self-citationClinical use and pharmacological properties of selective COX-2 inhibitors
Shi, S., & Klotz, U. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0400-7 · Cited by 179
Ozgoli, G., Goli, M., & Moattar, F. (2009) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2008.0311 · Cited by 178
Coco, A. (1999) · PubMed · Cited by 168
Nonsteroidal anti-inflammatory drugs for primary dysmenorrhoea
Marjoribanks, J., Proctor, M., Farquhar, C., Sangkomkamhang, U. S., & Derks, R. S. (2003) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001751 · Cited by 167
Self-citationEfficacy of minor analgesics in primary dysmenorrhoea: a systematic review
Zhang, W. Y., & Li Wan Po, A. (1998) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1998.tb10210.x · Cited by 165
Pitts, M. K., Ferris, J., Smith, A. M. A., SHELLEY, J. M., & Richters, J. (2008) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2008.tb01945.x · Cited by 160
Surgical treatment of primary dysmenorrhea with laparoscopic uterine nerve ablation.
Lichten, E. M., & Bombard, J. N. (1987) · PubMed · Cited by 148
Morrison, B. (1999) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(99)00360-9 · Cited by 130
Chinese herbal medicine for primary dysmenorrhoea
Zhu, X., Proctor, M. L., Bensoussan, A., Wu, E., & Smith, C. A. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005288.pub3 · Cited by 126
Self-citationProstaglandins in primary dysmenorrhea
Chan, W. Y., Dawood, M. Y., & Fuchs, F. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90576-3 · Cited by 116
Chan, W. Y., Dawood, M. Y., & Fuchs, F. (1979) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(79)80026-5 · Cited by 111
Smith, C. A., Zhu, X., He, L., & Song, J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007854.pub2 · Cited by 110
Behavioural interventions for dysmenorrhoea
Proctor, M. L., Murphy, P., Pattison, H. M., Suckling, J. A., & Farquhar, C. M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002248.pub3 · Cited by 95
Self-citationThe treatment of dysmenorrhea with naproxen sodium
Henzl, M. R., Buttram, V. C., Segre, E. J., & Bessler, S. A. (1977) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(77)90111-9 · Cited by 84
Dawood, M. Y., & Khan‐Dawood, F. S. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.06.091 · Cited by 79
Naproxen sodium in dysmenorrhea secondary to endometriosis.
Kauppila, A., & Rönnberg, L. (1985) · PubMed · Cited by 76
Valdecoxib, a Cyclooxygenase-2-Specific Inhibitor, Is Effective in Treating Primary Dysmenorrhea
Daniels, S., Talwalker, S., Torri, S., Snabes, M. C., Recker, D. P., & Verburg, K. M. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)02085-9 · Cited by 76
Work-related stress factors and menstrual pain: a nation-wide representative survey
László, K. D., Győrffy, Z., Ádám, S., Csoboth, C. T., & Kopp, M. (2008) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.1080/01674820701804423 · Cited by 75
Spinal manipulation for primary and secondary dysmenorrhoea
Proctor, M., Hing, W. A., Johnson, T., & Murphy, P. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002119 · Cited by 74
Self-citationChan, W., & Dawood, M. Y. (1980) · PubMed · Cited by 71
TRIAL OF PROSTAGLANDIN-SYNTHETASE INHIBITORS IN PRIMARY DYSMENORRHŒA
Anderson, A. M., Fraser, I. S., Haynes, P. J., et al. (1978) · The Lancet · doi:10.1016/s0140-6736(78)91077-2 · Cited by 68
Prostaglandin biosynthesis inhibitors and endometriosis
Kauppila, A., Puolakka, J. O., & Ylikorkala, O. (1979) · Prostaglandins · doi:10.1016/0090-6980(79)90033-9 · Cited by 67
Dynamics and significance of placebo response in primary dysmenorrhea
Fedele, L., Marchini, M., Acaia, B., Garagiola, U., & Tiengo, M. (1989) · Pain · doi:10.1016/0304-3959(89)90110-3 · Cited by 66
Chantler, I., Mitchell, D., & Fuller, A. (2008) · Journal of Pain · doi:10.1016/j.jpain.2008.08.006 · Cited by 66
Nonsteroidal Antiinflammatory Drugs — Differences and Similarities
(1991) · New England Journal of Medicine · doi:10.1056/nejm199112053252314 · Cited by 66
Valdecoxib for treatment of primary dysmenorrhea
Daniels, S. E., Torri, S. A., & Desjardins, P. J. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2004.30052.x · Cited by 56
Spinal manipulation for dysmenorrhoea
Proctor, M. L., Hing, W. A., Johnson, T. C., Murphy, P., & Brown, J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002119.pub3 · Cited by 55
Self-citationEffects of naproxen sodium on menstrual prostaglandins and primary dysmenorrhea.
Chan, W. Y., Fuchs, F. D., & Powell, A. M. (1983) · PubMed · Cited by 52
Milsom, I., & Andersch, B. (1984) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1984.tb15089.x · Cited by 51
The treatment of premenstrual tension with mefenamic acid: analysis of prostaglandin concentrations
Jakubowicz, D., GODARD, E., & Dewhurst, J. (1984) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1984.tb05283.x · Cited by 50
Doubova, S. V., Morales, H. R., Hernández, S. F., Martínez-García, M. D. C., Ortiz, M. G. G. D. C., Chávez-Soto, M. A., Rivera‐Arce, E., & Lozoya, X. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.09.033 · Cited by 49
Ibuprofen therapy for dysmenorrhea.
Sl, C., & Bolognese, R. J. (1978) · PubMed · Cited by 47
Daniels, S., Robbins, J. L., West, C. R., & Nemeth, M. A. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.06.003 · Cited by 40
Naproxen sodium in dysmenorrhea. Its influence in allowing continuation of work/school activities.
Fw, H., Izu, A., & Mr, H. (1978) · PubMed · Cited by 38
Roy, S. (1983) · PubMed · Cited by 36
The Effect of Three Cyclo-oxygenase Inhibitors on Intensity of Primary Dysmenorrheic Pain
Chantler, I., Mitchell, D., & Fuller, A. (2008) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e318156dafc · Cited by 31
Factors Influencing Adolescents' Responses to Regimens of Naproxen for Dysmenorrhea
DuRant, R. H. (1985) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1985.02140070063035 · Cited by 30
Mehlisch, D. R. (1990) · PubMed · Cited by 29
Mehlisch, D. R. (1988) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1988.tb05974.x · Cited by 29
Mehlisch, D. R., & FULMER, R. I. (1997) · Journal of Women s Health · doi:10.1089/jwh.1997.6.83 · Cited by 28
Analgesic Efficacy of Ibuprofen for Treatment of Primary Dysmenorrhea
Morrison, J. C., Ling, F. W., Forman, E. K., et al. (1980) · Southern Medical Journal · doi:10.1097/00007611-198008000-00014 · Cited by 27
Dysmenorrhea: treatment with an antiprostaglandin.
Rm, L., De, V. O., Poulson, A. M., & Scott (1979) · PubMed · Cited by 25
de Mello, N. R., Baracat, E. C., Tomaz, G., Bedone, A. J., Camargos, A. F., Barbosa, I., de Souza, R. N., Rumi, D. O., Alcalá, F. O. M., Velasco, J. A. A., et al. (2004) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1080/j.0001-6349.2004.00433.x · Cited by 25
The uterine contractility index: A research and diagnostic tool in dysmenorrhea
Schulman, H., Duvivier, R., & Blattner, P. (1983) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(83)90865-7 · Cited by 22
CLINICAL EXPERIENCE OF NAPROXEN IN THE TREATMENT OF PRIMARY DYSMENORRHEA
Dandenell, L., Lalos, O., Lisciak, J., et al. (1979) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016347909157800 · Cited by 21
Iacovides, S., Baker, F. C., & Avidon, I. (2013) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-013-3073-8 · Cited by 20
Pendergrass, P. B., Scott, J. N., Ream, L. J., et al. (2010) · Gynecologic and Obstetric Investigation · doi:10.1159/000299005 · Cited by 19
Beta2-adrenoceptor agonists for dysmenorrhoea
Fedorowicz, Z., Nasser, M., Jagannath, V. A., Beaman, J. H., Ejaz, K., & van Zuuren, E. J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008585.pub2 · Cited by 17
Eccles, R., Holbrook, A., & Jawad, M. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.525028 · Cited by 17
Arabic personal correspondence: a window on change in progress?
Belnap, R. K., & Bishop, B. (2003) · International Journal of the Sociology of Language · doi:10.1515/ijsl.2003.049 · Cited by 16
Åkerlund, M., & STRÖMBERG, P. (1989) · Current Medical Research and Opinion · doi:10.1185/03007998909110459 · Cited by 15
Milsom, I., & Andersch, B. (1985) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(85)90024-4 · Cited by 15
INDOMETHACIN IN THE TREATMENT OF PRIMARY DYSMENORRHOEA
Elder, M. G., & Kapadia, L. (1979) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1979.tb10828.x · Cited by 12
Naproxen sodium, ibuprofen and a placebo in dysmenorrhea.
Fw, H. (1982) · PubMed · Cited by 12
Worldwide Studies Comparing Piroxicam and Naproxen
Plantema, F. H. F. (1986) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016348509157061 · Cited by 11
Treating Dysmenorrhea with Anti‐inflammatory Agents: A Double‐Blind Trial With Naproxen Sodium
Sande, H. A., Salvesen, T., & Izu, A. (1978) · International Journal of Gynecology & Obstetrics · doi:10.1002/j.1879-3479.1978.tb00435.x · Cited by 11
Cited by
ESHRE guideline: management of women with endometriosis
Dunselman, G. A. J., Vermeulen, N., Becker, C., Calhaz-Jorge, C., D'Hooghe, T., De Bie, B., Heikinheimo, O., Horne, A. W., Kiesel, L., Nap, A., et al. (2014) · Human Reproduction · doi:10.1093/humrep/det457 · Cited by 2,211
Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective
Bindu, S., Mazumder, S., & Bandyopadhyay, U. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114147 · Cited by 1,920
Menstrual health: a definition for policy, practice, and research
Hennegan, J., Winkler, I. T., Bobel, C., Keiser, D., Hampton, J., Larsson, G., Chandra-Mouli, V., Plesons, M., & Mahon, T. (2021) · Sexual and Reproductive Health Matters · doi:10.1080/26410397.2021.1911618 · Cited by 449
Dysmenorrhea and related disorders
Bernardi, M., Lazzeri, L., Perelli, F., Reis, F. M., & Petraglia, F. (2017) · F1000Research · doi:10.12688/f1000research.11682.1 · Cited by 367
RETIRED: No. 345-Primary Dysmenorrhea Consensus Guideline
Burnett, M., & Lemyre, M. (2017) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2016.12.023 · Cited by 332
Metadata
- Authors
- Marjoribanks, J., Ayeleke, R. O., Farquhar, C., & Proctor, M.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2015-07-30
- Volume
- 2015
- Issue
- 7
- Pages
- CD001751-CD001751
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2109711640
- Cited by
- 562
- References
- 76
- FWCI
- 33.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.